Sisram Medical Balance Sheet Health
Financial Health criteria checks 5/6
Sisram Medical has a total shareholder equity of $472.5M and total debt of $5.4M, which brings its debt-to-equity ratio to 1.1%. Its total assets and total liabilities are $626.8M and $154.3M respectively. Sisram Medical's EBIT is $31.6M making its interest coverage ratio 18.5. It has cash and short-term investments of $70.8M.
Key information
1.1%
Debt to equity ratio
US$5.38m
Debt
| Interest coverage ratio | 18.5x |
| Cash | US$70.79m |
| Equity | US$472.53m |
| Total liabilities | US$154.28m |
| Total assets | US$626.81m |
Recent financial health updates
Does Sisram Medical (HKG:1696) Have A Healthy Balance Sheet?
Mar 28
Is Sisram Medical (HKG:1696) Using Too Much Debt?
Nov 09Is Sisram Medical (HKG:1696) Using Too Much Debt?
Apr 19Sisram Medical (HKG:1696) Has A Rock Solid Balance Sheet
Dec 21These 4 Measures Indicate That Sisram Medical (HKG:1696) Is Using Debt Safely
Aug 25Recent updates
Investors Could Be Concerned With Sisram Medical's (HKG:1696) Returns On Capital
Dec 11What Sisram Medical Ltd's (HKG:1696) 40% Share Price Gain Is Not Telling You
Oct 07Is There Now An Opportunity In Sisram Medical Ltd (HKG:1696)?
Aug 23Not Many Are Piling Into Sisram Medical Ltd (HKG:1696) Just Yet
Jul 24Increases to CEO Compensation Might Be Put On Hold For Now at Sisram Medical Ltd (HKG:1696)
Jun 17Returns On Capital At Sisram Medical (HKG:1696) Have Stalled
Apr 21Does Sisram Medical (HKG:1696) Have A Healthy Balance Sheet?
Mar 28Estimating The Intrinsic Value Of Sisram Medical Ltd (HKG:1696)
Mar 05Take Care Before Diving Into The Deep End On Sisram Medical Ltd (HKG:1696)
Jan 23Is Sisram Medical Ltd (HKG:1696) Potentially Undervalued?
Dec 29Is Sisram Medical (HKG:1696) Using Too Much Debt?
Nov 09Returns On Capital At Sisram Medical (HKG:1696) Have Stalled
Oct 19At HK$6.71, Is It Time To Put Sisram Medical Ltd (HKG:1696) On Your Watch List?
Sep 18Sisram Medical (HKG:1696) Is Paying Out A Larger Dividend Than Last Year
Aug 14Is There Now An Opportunity In Sisram Medical Ltd (HKG:1696)?
Jun 16Sisram Medical (HKG:1696) Shareholders Will Want The ROCE Trajectory To Continue
May 30Is Sisram Medical (HKG:1696) Using Too Much Debt?
Apr 19Is Now The Time To Look At Buying Sisram Medical Ltd (HKG:1696)?
Mar 01Sisram Medical (HKG:1696) Could Be Struggling To Allocate Capital
Jan 12Sisram Medical (HKG:1696) Has A Rock Solid Balance Sheet
Dec 21Should You Investigate Sisram Medical Ltd (HKG:1696) At HK$7.99?
Dec 01Some Investors May Be Worried About Sisram Medical's (HKG:1696) Returns On Capital
Oct 14Here's Why We Think Sisram Medical (HKG:1696) Is Well Worth Watching
Sep 28These 4 Measures Indicate That Sisram Medical (HKG:1696) Is Using Debt Safely
Aug 25Should You Think About Buying Sisram Medical Ltd (HKG:1696) Now?
Aug 01These 4 Measures Indicate That Sisram Medical (HKG:1696) Is Using Debt Safely
May 19Is Sisram Medical Ltd (HKG:1696) Trading At A 29% Discount?
May 03If You Like EPS Growth Then Check Out Sisram Medical (HKG:1696) Before It's Too Late
Apr 11Sisram Medical (HKG:1696) Is Experiencing Growth In Returns On Capital
Mar 17Is Now An Opportune Moment To Examine Sisram Medical Ltd (HKG:1696)?
Nov 22Calculating The Intrinsic Value Of Sisram Medical Ltd (HKG:1696)
Aug 22Be Wary Of Sisram Medical (HKG:1696) And Its Returns On Capital
Jul 27Financial Position Analysis
Short Term Liabilities: 1696's short term assets ($269.4M) exceed its short term liabilities ($102.8M).
Long Term Liabilities: 1696's short term assets ($269.4M) exceed its long term liabilities ($51.4M).
Debt to Equity History and Analysis
Debt Level: 1696 has more cash than its total debt.
Reducing Debt: 1696's debt to equity ratio has increased from 0.9% to 1.1% over the past 5 years.
Debt Coverage: 1696's debt is well covered by operating cash flow (741.4%).
Interest Coverage: 1696's interest payments on its debt are well covered by EBIT (18.5x coverage).
Balance Sheet
Discover healthy companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/02/07 16:43 |
| End of Day Share Price | 2025/02/07 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Sisram Medical Ltd is covered by 6 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Yuan Gao | China International Capital Corporation Limited |
| Yifan Du | Citic Securities Co., Ltd. |
| Eugene Huang | Jefferies LLC |